Precision Diagnostics Market to Grow at 16.48% CAGR through 2029F
Rising incidences of chronic diseases and expansion of
point-of-care testing (POCT) is expected to drive the Global Precision
Diagnostics Market growth in the forecast period, 2025-2029.
According to TechSci Research report, “Precision
Diagnostics Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2019-2029F”, the Global Precision Diagnostics
Market stood at USD 14.18 Billion in 2023 and is anticipated to project steady growth in
the forecast period with a CAGR of 16.48% through 2029.
Precision diagnostics have emerged as a cornerstone in
modern healthcare, offering tailored diagnostic and treatment solutions that
enhance patient outcomes and optimize healthcare delivery.
The intersection
of precision diagnostics with digital health technologies represents a
transformative leap forward in healthcare delivery, enhancing the ability to
monitor, diagnose, and treat patients more effectively and efficiently. Key
digital health innovations such as wearable devices, remote patient monitoring
systems, and mobile health applications are reshaping clinical practices by
enabling continuous, real-time data collection and analysis.
Wearable biosensors are at the forefront of this
revolution, offering capabilities beyond traditional healthcare settings. These
devices can monitor various physiological parameters, including heart rate
variability, oxygen saturation levels, and even biochemical markers like
glucose levels. For diabetic patients, continuous glucose monitoring (CGM)
systems provide clinicians with detailed insights into glucose fluctuations
throughout the day, facilitating personalized insulin dosing adjustments and
dietary recommendations. Such real-time data not only improves disease
management but also empowers patients to make informed decisions about their
health.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Precision Diagnostics Market”
Remote patient monitoring systems extend healthcare
beyond hospital walls, allowing healthcare providers to remotely monitor
patients' vital signs and health metrics from their homes. This is particularly
beneficial for chronic disease management, where regular monitoring of blood
pressure, heart rhythms, and medication adherence can prevent complications and
reduce hospitalizations. AI-powered algorithms analyze incoming data, flagging
deviations from baseline and alerting healthcare teams to potential issues
early, enabling timely interventions and proactive care.
Mobile health applications complement these
technologies by providing patients with personalized health coaching,
medication reminders, and access to their health records. Patients can actively
participate in their care management, track their progress, and communicate
securely with healthcare providers, promoting engagement and treatment
adherence.
The integration of precision diagnostics with digital
health not only enhances patient outcomes but also optimizes healthcare
resource allocation. By reducing unnecessary clinic visits, preventing hospital
admissions, and enabling more targeted interventions, these technologies
contribute to cost savings and operational efficiencies within healthcare
systems.
The Global Precision Diagnostics Market is segmented
into Type, application, End-Use, regional distribution, and company.
Based on application, In 2023 in the global precision
diagnostics market, oncology emerged as the dominant segment. This leadership
position is primarily driven by the increasing prevalence of cancer worldwide
and the critical role of precision diagnostics in improving cancer detection,
treatment selection, and patient outcomes. Precision diagnostics in oncology
involve advanced molecular profiling techniques such as next-generation
sequencing (NGS), liquid biopsies, and biomarker analysis. These technologies
enable oncologists to identify specific genetic mutations, biomarkers, and
molecular signatures associated with different types of cancer. Such insights
are instrumental in guiding personalized treatment strategies, including
targeted therapies and immunotherapies, which can effectively inhibit cancer
progression while minimizing side effects. The advent of companion diagnostics has significantly
bolstered the oncology segment within precision diagnostics. Companion
diagnostics are tests that identify biomarkers or genetic mutations that
predict a patient's response to a specific therapy. They play a crucial role in
determining which patients are likely to benefit from targeted therapies,
thereby optimizing treatment efficacy and patient outcomes. The prominence of oncology in the precision
diagnostics market is further underscored by ongoing research and development
efforts aimed at expanding the repertoire of biomarkers and therapeutic
targets. As molecular understanding of cancer continues to deepen and
technology advances, oncology-focused precision diagnostics are expected to
continue driving innovation and market growth in the years ahead, contributing
to more personalized and effective cancer care globally.
Based on region, after North America, Europe emerges
as the second dominating region in the Global Precision Diagnostics Market.
Europe's strong position is attributed to several factors contributing to its
significant market share. The region benefits from advanced healthcare systems,
well-established clinical research capabilities, and a high level of healthcare
expenditure, fostering the adoption of precision diagnostics. Regulatory bodies
such as the European Medicines Agency (EMA) ensure stringent but transparent
approval processes for new diagnostic technologies, supporting innovation and
market entry. Moreover, Europe's proactive approach towards healthcare policies
emphasizes personalized medicine and genomic research, driving the demand for
precision diagnostics that cater to individual patient needs. Collaborative
efforts between academia, healthcare institutions, and industry players further
promote technological advancements and the integration of precision diagnostics
into clinical practice. These factors collectively position Europe as a key
player in the global precision diagnostics market, facilitating continued
growth and innovation in healthcare delivery.
Major companies operating in Global Precision
Diagnostics Market are:
- Abbott
Laboratories Inc.
- F.
Hoffmann-La Roche Ltd.
- Siemens
Healthineers AG
- Thermo
Fisher Scientific Inc.
- bioMérieux
SA
- Becton,
Dickinson and Company
- Danaher
Corporation
- QIAGEN
N.V.
- Hologic
Inc.
- Agilent
Technologies Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The expansion of point-of-care testing (POCT)
represents another pivotal trend shaping the precision diagnostics market. POCT
devices enable rapid on-site diagnostic testing, delivering results within
minutes to hours directly at the patient's location, whether in a hospital,
clinic, or even at home. This immediacy is particularly advantageous in
emergency settings, rural areas with limited access to centralized
laboratories, and for monitoring chronic conditions in outpatient settings.
Technological advancements have miniaturized diagnostic tools and enhanced
their accuracy, sensitivity, and multiplexing capabilities, enabling
comprehensive testing for a wide range of conditions at the point of care. For
instance, handheld devices using molecular techniques like PCR or isothermal
amplification can diagnose infectious diseases such as COVID-19 or influenza
swiftly, guiding timely treatment decisions and infection control measures. The
growing demand for rapid and accurate diagnostic solutions, coupled with regulatory
approvals facilitating broader adoption of POCT devices, is driving market
growth in precision diagnostics.,” said Mr. Karan Chechi, Research Director of
TechSci Research, a research-based management consulting firm.
“Precision
Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, Segmented By Type (Genetic
Tests, Direct to Consumer Tests, Esoteric Tests, Others), By Application
(Oncology, Respiratory Diseases, Skin Diseases, CNS Disorders, Immunology,
Genetic Diseases, Others), By End-Use (Hospitals, Clinical Laboratories,
Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global
Precision Diagnostics Market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Precision
Diagnostics Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com